Protein glycation – biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine

Protein glycation provides a biomarker in widespread clinical use, glycated hemoglobin HbA(1c) (A1C). It is a biomarker for diagnosis of diabetes and prediabetes and of medium-term glycemic control in patients with established diabetes. A1C is an early-stage glycation adduct of hemoglobin with gluco...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabbani, Naila, Thornalley, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Articles from the Special Issue on Oxidative stress in retina and retinal pigment epithelium in health and disease; Edited by Dr. Vera Bonilha
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113047/
https://www.ncbi.nlm.nih.gov/pubmed/33707127
http://dx.doi.org/10.1016/j.redox.2021.101920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113047/
https://www.ncbi.nlm.nih.gov/pubmed/33707127
http://dx.doi.org/10.1016/j.redox.2021.101920

Ejemplares similares